Mallinckrodt Pharmaceuticals

Pharma

Mallinckrodt Pharmaceuticals is a US-based specialty pharmaceuticals company that focuses on developing, producing, and distributing innovative pharmaceutical products in areas such as pain management, autoimmune and rare diseases, and opioids. The company operates globally and has its headquarters in Staines-upon-Thames, UK where it employs over 3,500 people. Mallinckrodt's products include Acthar Gel, a drug for autoimmune and inflammatory disorders, and Amitiza, a treatment for chronic idiopathic constipation. The company also has a robust research and development program and is committed to ensuring patient safety and promoting responsible use of its products.